Retirement Systems of Alabama raised its holdings in shares of Zoetis Inc (NYSE:ZTS) by 0.3% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 222,938 shares of the company’s stock after acquiring an additional 741 shares during the quarter. Retirement Systems of Alabama’s holdings in Zoetis were worth $22,443,000 as of its most recent SEC filing.
Other large investors have also bought and sold shares of the company. Franklin Resources Inc. grew its position in shares of Zoetis by 28.2% during the third quarter. Franklin Resources Inc. now owns 14,964 shares of the company’s stock valued at $1,370,000 after purchasing an additional 3,288 shares in the last quarter. Standard Life Aberdeen plc grew its position in shares of Zoetis by 13.3% during the third quarter. Standard Life Aberdeen plc now owns 129,826 shares of the company’s stock valued at $11,887,000 after purchasing an additional 15,274 shares in the last quarter. Dynamic Technology Lab Private Ltd grew its position in shares of Zoetis by 33.1% during the third quarter. Dynamic Technology Lab Private Ltd now owns 3,195 shares of the company’s stock valued at $292,000 after purchasing an additional 795 shares in the last quarter. Advisors Asset Management Inc. grew its position in Zoetis by 6.9% in the third quarter. Advisors Asset Management Inc. now owns 34,724 shares of the company’s stock worth $3,179,000 after acquiring an additional 2,249 shares in the last quarter. Finally, Mackenzie Financial Corp grew its position in Zoetis by 6.8% in the third quarter. Mackenzie Financial Corp now owns 1,101,789 shares of the company’s stock worth $100,880,000 after acquiring an additional 70,235 shares in the last quarter. 90.84% of the stock is currently owned by institutional investors and hedge funds.
Shares of NYSE:ZTS opened at $99.17 on Wednesday. Zoetis Inc has a 1 year low of $77.00 and a 1 year high of $103.33. The company has a market cap of $47.52 billion, a price-to-earnings ratio of 31.68, a price-to-earnings-growth ratio of 1.84 and a beta of 0.93. The company has a quick ratio of 2.46, a current ratio of 3.60 and a debt-to-equity ratio of 2.95.
Zoetis (NYSE:ZTS) last announced its earnings results on Thursday, February 14th. The company reported $0.79 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $0.77 by $0.02. Zoetis had a return on equity of 73.85% and a net margin of 24.51%. The business had revenue of $1.56 billion during the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the previous year, the business earned $0.69 earnings per share. The company’s revenue for the quarter was up 7.1% compared to the same quarter last year. Analysts anticipate that Zoetis Inc will post 3.46 EPS for the current fiscal year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, June 3rd. Shareholders of record on Thursday, April 18th will be given a dividend of $0.164 per share. The ex-dividend date of this dividend is Wednesday, April 17th. This represents a $0.66 annualized dividend and a dividend yield of 0.66%. Zoetis’s dividend payout ratio (DPR) is presently 21.09%.
In other Zoetis news, insider Catherine A. Knupp sold 32,767 shares of the business’s stock in a transaction that occurred on Tuesday, March 5th. The stock was sold at an average price of $95.80, for a total transaction of $3,139,078.60. Following the completion of the transaction, the insider now owns 82,820 shares in the company, valued at $7,934,156. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Kristin C. Peck sold 11,500 shares of the business’s stock in a transaction that occurred on Tuesday, February 12th. The shares were sold at an average price of $86.79, for a total value of $998,085.00. The disclosure for this sale can be found here. Insiders have sold 410,333 shares of company stock valued at $38,674,547 in the last 90 days. Company insiders own 0.29% of the company’s stock.
ZTS has been the subject of several recent research reports. Zacks Investment Research lowered Zoetis from a “hold” rating to a “sell” rating in a research report on Monday, February 4th. UBS Group initiated coverage on Zoetis in a research report on Wednesday, January 23rd. They issued a “neutral” rating and a $86.00 price target for the company. Stifel Nicolaus upgraded Zoetis from a “hold” rating to a “buy” rating and lifted their price target for the stock from $97.00 to $110.00 in a research report on Monday, March 4th. SunTrust Banks initiated coverage on Zoetis in a research report on Tuesday, March 19th. They issued a “hold” rating and a $100.00 price target for the company. Finally, BMO Capital Markets lifted their price target on Zoetis from $93.00 to $101.00 and gave the stock a “market perform” rating in a research report on Monday, February 25th. Six investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. The company currently has an average rating of “Buy” and an average target price of $100.57.
ILLEGAL ACTIVITY NOTICE: This article was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this article on another site, it was illegally stolen and republished in violation of U.S. and international trademark & copyright law. The legal version of this article can be viewed at https://www.dispatchtribunal.com/2019/04/17/zoetis-inc-zts-holdings-raised-by-retirement-systems-of-alabama.html.
Zoetis Inc discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses.
Featured Story: Producer Price Index (PPI)
Want to see what other hedge funds are holding ZTS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zoetis Inc (NYSE:ZTS).
Receive News & Ratings for Zoetis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zoetis and related companies with MarketBeat.com's FREE daily email newsletter.